-
Ahead of this year’s MDA Conference, association’s CEO speaks of ‘hope’
Next week, researchers, clinicians, industry leaders, and families will gather at the 2026 MDA Clinical
-
Clinical Research Alert: Phase 2 Study of NMD670 in Adults with Generalized Myasthenia Gravis (gMG)
Researchers at NMD Pharma A/S are working to better understand generalized myasthenia gravis (gMG) and study








